Live
Upcoming Events
Treatment for Patients with Locally Advanced Unresectable NSCLC - Targeted Therapies in Lung Cancer
Before Surgery, Patients with Resectable NSCLC & Driver Mutation - Targeted Therapies in Lung Cancer
Immunotherapy for Patients with Resectable NSCLC & Driver Mutation-Targeted Therapies in Lung Cancer
The Alina Trial for ALK+ NSCLC - Targeted Therapies in Lung Cancer 2023
The Alina Trial for ALK+ NSCLC - Targeted Therapies in Lung Cancer 2023
Key Points from the Adaura Trial: Osimertinib - Targeted Therapies in Lung Cancer 2023
The Adaura Trial: The Effect on EGFR+ Treatment - Targeted Therapies in Lung Cancer 2023
Biomarker Driven Therapy for NSCLC - Targeted Therapies in Lung Cancer 2023
Barriers to Biomarker Testing: Cost and Insurance - Targeted Therapies in Lung Cancer 2023
Barriers to Biomarker Testing: Ordering Tests - Targeted Therapies in Lung Cancer 2023
Amivantamab Combo in EGFR Exon 20 NSCLC: PAPILLON Results Nicolas Girard, MD
The Role of Immunotherapy in Patients with Brain Metastases - Kim Margolin, MD